HIV testing rate | HIV case finding | |||||||
---|---|---|---|---|---|---|---|---|
OPD only | n/N (%) | aOR | (95 % CI) | P | n/N (%) | aOR | (95 % CI) | P |
Study phase | ||||||||
Phase 1 | 1,234/26,367 (4.7 %) | 1 | <0.001 | 67/26,367 (0.25 %) | 1 | <0.001 | ||
Phase 3 | 5,065/29,864 (17 %) | 4.57 | (4.26-4.90) | 136/29,864 (0.46 %) | 1.97 | (1.41-2.76) | ||
Study site | ||||||||
Ruhengeri | 807/9,088 (8.9 %) | 1 | <0.001 | 19/9,088 (0.21 %) | 1 | <0.001 | ||
Muhoza | 1,732/18,892 (9.2 %) | 1.18 | (1.08-1.30) | 53/18,892 (0.28 %) | 1.87 | (1.06-3.31) | ||
Kibagabaga | 553/5,596 (9.9 %) | 0.79 | (0.69-0.89) | 41/5,596 (0.73 %) | 3.10 | (1.69-5.68) | ||
Kinyinya | 345/6,072 (5.7 %) | 0.55 | (0.48-0.63) | 25/6,072 (0.41 %) | 2.32 | (1.24-4.35) | ||
Kimironko | 992/10,659 (9.3 %) | 0.97 | (0.88-1.08) | 52/10,659 (0.49 %) | 3.13 | (1.78-5.51) | ||
Rwaza | 1,870/5,924 (31.6 %) | 4.65 | (4.21-5.13) | 13/5,924 (0.22 %) | 1.19 | (0.57-2.49) | ||
Sex | ||||||||
Females | 3,685/34,610 (10.7 %) | 1 | <0.001 | 111/34,610 (0.32 %) | 1 | 0.078 | ||
Males | 2,597/21,035 (12.4 %) | 1.19 | (1.13-1.26) | 92/21,035 (0.44 %) | 1.30 | (0.98-1.73) | ||
Age group (years) | ||||||||
15 - 24 | 2,275/19,643 (11.6 %) | 1 | <0.001 | 35/19,643 (0.18 %) | 1 | <0.001 | ||
25 - 34 | 1,732/16,687 (10.4 %) | 0.93 | (0.87-1.00) | 65/16,687 (0.39 %) | 2.09 | (1.38-3.16) | ||
35 - 44 | 863/7,648 (11.3 %) | 0.92 | (0.84-1.01) | 48/7,648 (0.63 %) | 3.73 | (2.41-5.78) | ||
≥45 | 1,270/11,470 (11.1 %) | 0.77 | (0.71-0.83) | 42/11,470 (0.37 %) | 2.38 | (1.52-3.71) | ||
OPD & VCT combined | n/N (%) | aOR | (95 % CI) | P | n/N (%) | aOR | (95 % CI) | P |
Study phase | ||||||||
Phase 1 | 5,779/30,914 (18.7 %) | 1 | <0.001 | 311/30,914 (1.01 %) | 1 | <0.001 | ||
Phase 3 | 8,442/33,242 (25.4 %) | 1.67 | 1.60-1.73 | 348/33,242 (1.05 %) | 1.09 | 0.93-1.28 | ||
Study site | ||||||||
Ruhengeri | 807/9,088 (8.9 %) | 1 | <0.001 | 19/9,088 (0.21 %) | 1 | <0.001 | ||
Muhoza | 6,673/23,833 (28.0 %) | 3.95 | 3.65-4.28 | 270/23,833 (1.13 %) | 6.26 | 3.78-10.38 | ||
Kibagabaga | 959/6,004 (16.0 %) | 1.49 | 1.34-1.66 | 104/6,004 (1.73 %) | 8.27 | 4.87-14.06 | ||
Kinyinya | 1,223/6,950 (17.6 %) | 1.91 | 1.73-2.10 | 94/6,950 (1.35 %) | 7.22 | 4.25-12.28 | ||
Kimironko | 1,763/11,431 (15.4 %) | 1.58 | 1.44-1.73 | 153/11,431 (1.34 %) | 7.39 | 4.41-12.38 | ||
Rwaza | 2,796/6,850 (40.8 %) | 7.04 | 6.43-7.70 | 19/6,850 (0.28 %) | 1.57 | 0.81-3.06 | ||
Sex | 0.417 | |||||||
Females | 8,242/39,170 (21.0 %) | 1 | <0.001 | 413/39,170 (1.05 %) | 1 | |||
Males | 5,959/24,397 (24.4 %) | 1.34 | 1.29-1.39 | 246/24,397 (1.01 %) | 0.93 | 0.80-1.10 | ||
Age group (years) | ||||||||
15 - 24 | 5,498/22,867 (24.0 %) | 1 | <0.001 | 157/22,867 (0.69 %) | 1 | <0.001 | ||
25 - 34 | 4,728/19,685 (24.0 %) | 1.11 | 1.06-1.16 | 270/19,685 (1.37 %) | 2.02 | 1.65-2.46 | ||
35 - 44 | 1,887/8,672 (21.8 %) | 0.91 | 0.85-0.96 | 128/8,672 (1.48 %) | 2.42 | 1.91-3.06 | ||
≥45 | 1,933/12,133 (15.9 %) | 0.54 | 0.51-0.58 | 90/12,133 (0.74 %) | 1.34 | 1.03-1.73 |